Found 95 matching trials
Pharmacokinetic Study of LAF237 and Its Metabolites in Mild Renal Impaired Patients
PHASE1This study will evaluate the pharmacokinetics of vildagliptin (LAF237) and ...
Location
Novartis Investigator Site
Nitazoxanide as Adjuvant Therapy in Type 2 Diabetes Mellitus
PHASE2Diabetes mellitus (DM) is a complex metabolic disorder characterized by hyp...
Location
Faculty of medicine, Tanta University
DBPR108 Tablets in Type 2 Diabetes Mellitus Patients
PHASE2This study evaluate DRBP108 in the treatment of type 2 diabetes mellitus. T...
Location
First Hospital of Peking Unversity
Empagliflozin in Treatment of Peripheral Diabetic Neuropathy
PHASE1The aim of the study is to investigate the possible protective effect of em...
Location
Faculty of pharmacy
The Effect of DPP4 Inhibitor on Vasclular Healing
PHASE4This study evaluate the effect of dipeptidyl-peptidase 4 inhibitor on vascu...
Location
Keimyung University Hospital
Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
NAOur trial goal is to determine the efficacy and safety of sitagliptin in co...
Location
University of Sadat City
Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)
PHASE3There are recent advances in therapies for the treatment of Type 2 Diabetes...
Location
University Hospitals of Leicester NHS Trust, Diabetes Research Centre
The DPP-4 Inhibitor Vildagliptin as Adjunct in Major Depressive Disorder Patients
PHASE1Vildagliptin, an antidiabetic drug that inhibits the dipeptidyl peptidase- ...
Location
Faculty of Medicine
Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
PHASE3Saxagliptin is a new investigational medication being developed for treatme...
Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVD
PHASE4The purpose of this study is to assess an inhibitory effect of Evogliptin o...
Location
Asan Medical Center